-The Economic Times New discoveries of natural resources in several African countries - including Ghana, Uganda, Tanzania, and Mozambique - raise an important question: will these windfalls be a blessing that brings prosperity and hope, or a political and economic curse, as has been the case in so many countries? On average, resource-rich countries have done even more poorly than countries without resources. They have grown more slowly, and with greater inequality...

Two sets of government data on UPA government's most famous flagship programme Mahatma Gandhi National Rural Employment Guarantee Act (MNREGA), for which Rs. 33000 crore was earmarked in 2012-13 budget, provide widely different figures for several states, a feature which experts say is indicative of the corruption in the scheme and weakness of social audit or accountability. The government has increasingly relied on Management Information System (MIS) for monitoring NREGA at...

-The Hindu Business Line India can learn from Brazil’s Bolsa Familia and China’s Gansu Programme to make refinements to its MGNREGA scheme. The development experiences of Brazil, China and India provide a valuable opportunity to understand the relationship between growth and distribution over periods of high rates of growth. The growth story playing out in all the three emerging economies have resulted in large regional as well as spatial inequalities, between rural and...

-Outlook Why free mobiles to BPL folks is a bad idea  “Here you don’t have money to provide them food, and you are thinking of giving them phones,” scoffs a minister in the UPA government, obviously off the record. His comment mirrors the general negative reaction to the ‘Har Haath Mein Phone’ scheme mooted by the Planning Commission, which aims to provide a free mobile phone to each below the poverty line...

-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...